Netherlands Wound Care Management Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 235 Pages

Table of Contents

1 Table Of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Wound Care Management

3 Healthcare Sector Review

3.1 Healthcare Expenditure

3.2 Healthcare Infrastructure

3.3 Healthcare Policy

3.3.1 Health Insurance Act

3.3.2 Healthcare Allowance Act

3.3.3 The Exceptional Medical Expenses Act

4 Wound Care Management in Netherlands

4.1 Wound Care Management Overall Revenues (2000-2012)

4.2 Wound Care Management Overall Volume (2000-2012)

4.3 Wound Care Management Overall Company Shares (2005-2006)

5 Wound Closure Devices in Netherlands

5.1 Wound Closure Devices Overall Revenues (2000-2012)

5.1.1 Skin Closure Devices Overall Revenues (2000-2012)

5.1.2 Hemostats Overall Revenues (2000-2012)

5.1.3 Tissue Sealants Overall Revenues (2000-2012)

5.2 Wound Closure Devices Overall Volume (2000-2012)

5.2.1 Skin Closure Devices Overall Volume (2000-2012)

5.2.2 Tissue Sealants Overall Volume (2000-2012)

5.2.3 Hemostats Overall Volume (2000-2012)

5.3 Wound Closure Devices Average Price (2000-2012)

5.3.1 Hemostats Average Price (2000-2012)

5.3.2 Tissue Sealants Average Price (2000-2012)

5.3.3 Skin Closure Devices Average Price (2000-2012)

5.4 Wound Closure Devices Distribution Share (2000-2012)

5.5 Wound Closure Devices Company Share (2000-2012)

6 Ostomy in Netherlands

6.1 Ostomy Overall Revenue (2000-2012)

6.2 Ostomy Overall Volume (2000-2012)

6.3 Ostomy Average Price (2000-2012)

6.4 Ostomy Distribution Share (2005-2006)

6.5 Ostomy Company Share (2005-2006)

7 Advanced Wound Management in Netherlands

7.1 Advanced Wound Management Overall Revenue (2000-2012)

7.2 Advanced Wound Management Overall Volume (2000-2012)

7.3 Advanced Wound Management Average Price (2000-2012)

7.4 Advanced Wound Management Distribution Share (2005-2006)

7.5 Advanced Wound Management Company Share (2005-2006)

8 Traditional Wound Management in Netherlands

8.1 Traditional Wound Management Overall Revenue (2000-2012)

8.2 Traditional Wound Management Overall Volume (2000-2012)

8.3 Traditional Wound Management Average Price (2000-2012)

8.4 Traditional Wound Management Distribution Share (2000-2012)

8.5 Traditional Wound Management Company Share (2000-2012)

9 Compression Therapy in Netherlands

9.1 Compression Therapy Overall Revenue (2000-2012)

9.2 Compression Therapy Category Volume (2000-2012)

9.3 Compression Therapy Average Price (2000-2012)

9.4 Compression Therapy Distribution Share (2000-2012)

9.5 Compression Therapy Company Share (2000-2012)

10 Baxter International Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 BioScience

10.2.2 Medication Delivery

10.2.3 Renal

10.2.4 Products

10.2.5 History

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 Baxter International Inc. Strengths

10.4.2 Baxter International Inc. Weaknesses

10.4.3 Baxter International Inc. Opportunities

10.4.4 Baxter International Inc. Threats

10.5 Financial and Operational Review

10.6 Locations And Subsidiaries

10.7 Financial Deals Landscape

10.7.1 Baiyunshan And Baxter Form A Joint Venture In China

10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration

10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital

10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter

10.7.5 Innovata signs a license agreement with Baxter International

10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International

10.7.7 Gambro Signs An Agreement With Baxter

10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement

10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System

10.7.10 Baxter International And Kaketsuken Enter Into Agreement

10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful

10.8 Recent Developments

10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007

10.8.2 Dec 18, 2007: Baxter Elects CFO

10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend

10.8.4 Aug 01, 2007: Baxter Elects New Board Director

10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend

10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization

10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend

10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend

10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America

10.9 Baxter International Inc. Pipeline Products

10.9.1 Next-Generation Home Hemodialysis Machine

11 Smith & Nephew Plc Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Advanced Wound Management

11.2.2 Endoscopy

11.2.3 Reconstruction

11.2.4 Trauma and Clinical Therapies

11.2.5 Products

11.2.6 History

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 Smith & Nephew Plc Strengths

11.4.2 Smith & Nephew Plc Weaknesses

11.4.3 Smith & Nephew Plc Opportunities

11.4.4 Smith & Nephew Plc Threats

11.5 Financial and Operational Review

11.6 Locations And Subsidiaries

11.7 Financial Deals Landscape

11.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein

11.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services

11.7.3 Smith & Nephew Acquires Plus Orthopedics Holding

11.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement

11.7.5 Smith & Nephew Acquires BlueSky Medical Group

11.7.6 Smith & Nephew Enters Into An Agreement With Covalon

11.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories

11.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew

11.7.9 Smith & Nephew Acquires Osteobiologics

11.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement

11.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity

11.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew

11.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies

11.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft

11.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement

11.7.16 Smith & Nephew Acquires VERSAJET From HydroCision

11.7.17 Smith & Nephew Terminates Acquisition Of Biomet

11.8 Recent Developments

11.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend

11.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results

11.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation

11.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM

11.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails

11.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend

11.8.7 May 03, 2007: Smith & Nephew Appoints New CEO

11.9 Smith & Nephew Plc Pipeline Products

11.9.1 R3 Modular resurfacing Acetabular system

11.9.2 R3 Ceramic-on-ceramic Acetabular System

12 The HARTMANN GROUP Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Incontinence Management

12.2.2 Operating Theater Management

12.2.3 Other GROUP Activities

12.2.4 Wound Management

12.2.5 Products

12.2.6 History

12.3 Value Chain Analysis

12.3.1 Manufacturing

12.3.2 Product Development

12.3.3 Sales and Marketing

12.4 SWOT Analysis

12.4.1 HARTMANN GROUP Strengths

12.4.2 HARTMANN GROUP Weaknesses

12.4.3 HARTMANN GROUP Opportunities

12.4.4 HARTMANN GROUP Threats

12.5 Financial and Operational Review

12.6 Locations And Subsidiaries

12.7 Recent Developments

12.7.1 Mar 17, 2008: Hartmann Declares 2007 Results

12.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia

12.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm

12.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results

13 Coloplast A/S Company Profile

13.1 Company Overview

13.2 Business Overview

13.2.1 Medical Care

13.2.2 Major Products and Services

13.2.3 History

13.3 Value Chain Analysis

13.3.1 Manufacturing

13.3.2 Product Development

13.3.3 Sales and Marketing

13.4 SWOT Analysis

13.4.1 Coloplast A/S Strengths

13.4.2 Coloplast A/S Weaknesses

13.4.3 Coloplast A/S Opportunities

13.4.4 Coloplast A/S Threats

13.5 Financial and Operational Review

13.5.1 Financial Statements

13.5.2 Financial Ratios

13.5.3 Share Holding Structure

13.6 Locations And Subsidiaries

13.7 Financial Deals Landscape

13.7.1 Coloplast Sells Brachytherapy Business To Core Oncology

13.7.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies

13.7.3 Granville Baird Capital Partners Advisors Acquires Coloplast’s Business Unit

13.7.4 McKesson Corporation Acquires Sterling Medical Services

13.7.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor

13.8 Recent Developments

13.8.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary

13.8.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results

13.8.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results

13.8.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results

13.8.5 May 15, 2007: Colplast Declares H1 2007 Results

13.8.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results

13.8.7 Dec 13, 2006: Coloplast Appoints New Chairman

13.8.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results

14 ConvaTec Company Profile

14.1 Company Overview

14.2 Business Overview

14.2.1 Major Products and Services

14.2.2 History

14.3 Locations And Subsidiaries

14.4 Recent Developments

14.4.1 Jan 22, 2008: Vivolution Acquires Patent From BMS

14.4.2 Nov 12, 2007: Alltracel Signs Development Agreement With ConvaTec

15 Regulation System

15.1 Medical Equipment Approval Process

15.1.1 Classification of Medical Devices

15.1.2 Conformity Assessment Process

15.2 Post Market Surveillance (PMS)

16 Pricing and Reimbursement

16.1 Pricing and Reimbursement in Netherlands

17 Distribution Structure

17.1 Distribution Structure in Netherlands

18 APPENDIX

18.1 Global Markets Direct Research Methodology

18.2 Coverage

18.3 Secondary Research

18.4 Primary Research

18.5 Models

18.6 Forecasts

18.7 Expert Panels

18.8 Currency Conversion

18.9 Contact Us

18.10 Disclaimer

1.1 List of Tables

Table 1: Doctors by Specialty in Netherlands, 2000-2006

Table 2: Hospital Wards by Type in Netherlands, 2000-2006

Table 3: Wound Care Management, Netherlands, Overall Revenues ($ mn), 2000-2012

Table 4: Wound Care Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 5: Wound Care Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 6: Wound Care Management, Netherlands, Category Revenues ($ mn), 2000-2012

Table 7: Wound Care Management, Netherlands, Category Revenues ($ mn), Historic, 2000-2007

Table 8: Wound Care Management, Netherlands, Category Revenues ($ mn), Forecast, 2007-2012

Table 9: Wound Care Management, Netherlands, Category Volume (Units), 2000-2012

Table 10: Wound Care Management, Netherlands, Category Volume (Units), Historic, 2000-2007

Table 11: Wound Care Management, Netherlands, Category Volume (Units), Forecast, 2007-2012

Table 12: Wound Care Management, Netherlands, Overall Company Share by Revenue ($ mn), 2005-2006

Table 13: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 14: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 15: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Historic, 2000-2007

Table 16: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 17: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 18: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 19: Hemostats, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 20: Hemostats, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 21: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 22: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 23: Wound Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007

Table 24: Wound Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Table 25: Skin Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007

Table 26: Skin Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Table 27: Tissue Sealants, Netherlands, Overall Volume (Units), Historic, 2000-2007

Table 28: Tissue Sealants, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Table 29: Hemostats, Netherlands, Overall Volume (Units), Historic, 2000-2007

Table 30: Hemostats, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Table 31: Hemostats, Netherlands, Average Price ($), Historic, 2000-2007

Table 32: Hemostats, Netherlands, Average Price ($), Forecast, 2007-2012

Table 33: Tissue Sealants, Netherlands, Average Price ($), Historic, 2000-2007

Table 34: Tissue Sealants, Netherlands, Average Price ($), Forecast, 2007-2012

Table 35: Skin Closure Devices, Netherlands, Average Price ($), Historic, 2000-2007

Table 36: Skin Closure Devices, Netherlands, Average Price ($), Forecast, 2007-2012

Table 37: Wound Closure Devices, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006

Table 38: Wound Closure Devices, Netherlands, Company Share by Revenue ($ mn), 2005-2006

Table 39: Ostomy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 40: Ostomy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 41: Ostomy, Netherlands, Overall Volume (Units), Historic, 2000-2007

Table 42: Ostomy, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Table 43: Ostomy, Netherlands, Average Price ($), Historic, 2000-2007

Table 44: Ostomy, Netherlands, Average Price ($), Forecast, 2007-2012

Table 45: Ostomy, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006

Table 46: Ostomy, Netherlands, Company Share by Revenue ($ mn), 2005-2006

Table 47: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 48: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 49: Advanced Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007

Table 50: Advanced Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Table 51: Advanced Wound Management, Netherlands, Average Price ($), Historic, 2000-2007

Table 52: Advanced Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012

Table 53: Advanced Wound Management, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006

Table 54: Advanced Wound Management, Netherlands, Company Share by Revenue ($ mn), 2005-2006

Table 55: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 56: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 57: Traditional Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007

Table 58: Traditional Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Table 59: Traditional Wound Management, Netherlands, Average Price ($), Historic, 2000-2007

Table 60: Traditional Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012

Table 61: Traditional Wound Management, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006

Table 62: Traditional Wound Management, Netherlands, Company Share by Revenue ($ mn), 2005-2006

Table 63: Compression Therapy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Table 64: Compression Therapy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Table 65: Compression Therapy, Netherlands, Overall Volume (Units), Historic, 2000-2007

Table 66: Compression Therapy, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Table 67: Compression Therapy, Netherlands, Average Price ($), Historic, 2000-2007

Table 68: Compression Therapy, Netherlands, Average Price ($), Forecast, 2007-2012

Table 69: Compression Therapy, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006

Table 70: Compression Therapy, Netherlands, Company Share by Revenue ($ mn), 2005-2006

Table 71: Baxter International Inc., SWOT Analysis, 2006

Table 72: Baxter International Inc., Financial Statements, USD Million, 2002-2006

Table 73: Baxter International Inc., Financial Ratios, USD Million, 2002-2006

Table 74: Baxter International Inc., Other Locations

Table 75: Baxter International Inc., Subsidiaries

Table 76: Smith & Nephew Plc, SWOT Analysis, 2006

Table 77: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006

Table 78: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006

Table 79: Smith & Nephew Plc, Other Locations

Table 80: HARTMANN GROUP, SWOT Analysis, 2006

Table 81: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006

Table 82: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006

Table 83: HARTMANN GROUP, Subsidiaries

Table 84: Coloplast A/S, SWOT Analysis, 2007

Table 85: Coloplast A/S, Financial Statements, DKK Million, 2003-2007

Table 86: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007

Table 87: Coloplast A/S, Share Holding Structure

Table 88: Coloplast A/S, Other Locations

Table 89: Coloplast A/S, Subsidiaries

Table 90: ConvaTec, Other Locations

Table 91: Currency Conversion from USD to Local Currency at 2007 Constant Rate

1.2 List of Figures

Figure 1: Total Healthcare Expenditure in Netherlands, 2000 - 2006

Figure 2: Healthcare Financing Framework in Netherlands, 2005

Figure 3: Wound Care Management, Netherlands, Overall Revenues ($ mn), 2000-2012

Figure 4: Wound Care Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 5: Wound Care Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 6: Wound Care Management, Netherlands, Category Revenues ($ mn), 2000-2012

Figure 7: Wound Care Management, Netherlands, Category Revenues ($ mn), Historic, 2000-2007

Figure 8: Wound Care Management, Netherlands, Category Revenues ($ mn), Forecast, 2007-2012

Figure 9: Wound Care Management, Netherlands, Category Volume (Units), 2000-2012

Figure 10: Wound Care Management, Netherlands, Category Volume (Units), Historic, 2000-2007

Figure 11: Wound Care Management, Netherlands, Category Volume (Units), Forecast, 2007-2012

Figure 12: Wound Care Management, Netherlands, Overall Company Share (%), 2006

Figure 13: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 14: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 15: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 16: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 17: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 18: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 19: Hemostats, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 20: Hemostats, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 21: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 22: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 23: Wound Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007

Figure 24: Wound Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Figure 25: Skin Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007

Figure 26: Skin Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Figure 27: Tissue Sealants, Netherlands, Overall Volume (Units), Historic, 2000-2007

Figure 28: Tissue Sealants, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Figure 29: Hemostats, Netherlands, Overall Volume (Units), Historic, 2000-2007

Figure 30: Hemostats, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Figure 31: Hemostats, Netherlands, Average Price ($), Historic, 2000-2007

Figure 32: Hemostats, Netherlands, Average Price ($), Forecast, 2007-2012

Figure 33: Tissue Sealants, Netherlands, Average Price ($), Historic, 2000-2007

Figure 34: Tissue Sealants, Netherlands, Average Price ($), Forecast, 2007-2012

Figure 35: Skin Closure Devices, Netherlands, Average Price ($), Historic, 2000-2007

Figure 36: Skin Closure Devices, Netherlands, Average Price ($), Forecast, 2007-2012

Figure 37: Wound Closure Devices, Netherlands, Distribution Share (%), 2006

Figure 38: Wound Closure Devices, Netherlands, Company Share (%), 2006

Figure 39: Ostomy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 40: Ostomy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 41: Ostomy, Netherlands, Overall Volume (Units), Historic, 2000-2007

Figure 42: Ostomy, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Figure 43: Ostomy, Netherlands, Average Price ($), Historic, 2000-2007

Figure 44: Ostomy, Netherlands, Average Price ($), Forecast, 2007-2012

Figure 45: Ostomy, Netherlands, Company Share (%), 2006

Figure 46: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 47: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 48: Advanced Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007

Figure 49: Advanced Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Figure 50: Advanced Wound Management, Netherlands, Average Price ($), Historic, 2000-2007

Figure 51: Advanced Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012

Figure 52: Advanced Wound Management, Netherlands, Distribution Share (%), 2006

Figure 53: Advanced Wound Management, Netherlands, Company Share (%), 2006

Figure 54: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 55: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 56: Traditional Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007

Figure 57: Traditional Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Figure 58: Traditional Wound Management, Netherlands, Average Price ($), Historic, 2000-2007

Figure 59: Traditional Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012

Figure 60: Traditional Wound Management, Netherlands, Distribution Share (%), 2006

Figure 61: Traditional Wound Management, Netherlands, Company Share (%), 2006

Figure 62: Compression Therapy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007

Figure 63: Compression Therapy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 64: Compression Therapy, Netherlands, Overall Volume (Units), Historic, 2000-2007

Figure 65: Compression Therapy, Netherlands, Overall Volume (Units), Forecast, 2007-2012

Figure 66: Compression Therapy, Netherlands, Average Price ($), Historic, 2000-2007

Figure 67: Compression Therapy, Netherlands, Average Price ($), Forecast, 2007-2012

Figure 68: Compression Therapy, Netherlands, Distribution Share (%), 2006

Figure 69: Compression Therapy, Netherlands, Company Share (%), 2006

Figure 70: Baxter International Inc., Value Chain Analysis

Figure 71: Smith & Nephew Plc, Value Chain Analysis

Figure 72: HARTMANN GROUP, Value Chain Analysis

Figure 73: Coloplast A/S, Value Chain Analysis

Figure 74: Flowchart for Classification of Non-invasive Devices in Netherlands, 2007

Figure 75: Flowchart for Classification of Invasive Devices in Netherlands, 2007

Figure 76: Flowchart for Classification of Invasive Devices in Netherlands, 2007

Figure 77: Flowchart for Classification of Invasive Devices in Netherlands, 2007

Figure 78: Flowchart for Classification of Invasive Devices in Netherlands, 2007

Figure 79: Flowchart for Classification of Active Devices in Netherlands, 2007

Figure 80: Flowchart for Classification of Active Devices in Netherlands, 2007

Figure 81: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Netherlands, 2007

Figure 82: Conformity Assessment of Class-I Medical Devices in Netherlands, 2007

Figure 83: Conformity Assessment of Class-IIa Medical Devices in Netherlands, 2007

Figure 84: Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007

Figure 85: Conformity Assessment of Class-III Medical Devices in Netherlands, 2007

Figure 86: Global Markets Direct Methodology

Abstract

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.